>>> US Research Calls

Research Calls I
  • Upgrades
    • Apple (AAPL) upgraded to Neutral from Sell at MoffettNathanson, tgt $225
    • Airbus (EADSY) upgraded to Buy from Neutral at UBS
    • Brinker (EAT) upgraded to Outperform from In Line at Evercore ISI, tgt $210
    • Copart (CPRT) upgraded to Buy from Hold at HSBC, tgt $62
    • Leidos (LDOS) upgraded to Outperform from Sector Perform at RBC Capital, tgt $210
  • Downgrades
    • Duolingo (DUOL) downgraded to Neutral from Buy at DA Davidson, tgt $300
    • Kilroy Realty (KRC) downgraded to Equal Weight from Overweight at Barclays, tgt $43
    • Navient (NAVI) downgraded to Underperform from Neutral at BofA Securities, tgt $12
    • Neonode (NEON) downgraded to Neutral from Buy at Ladenburg, tgt $6
    • Parker-Hannifin (PH) downgraded to Hold from Buy at Deutsche Bank, tgt $809
    • Texas Roadhouse (TXRH) downgraded to In Line from Outperform at Evercore ISI, tgt $190
  • Others
    • 89bio (ETNB) assumed with a Buy at H.C. Wainwright, tgt $32
    • Akero Therapeutics (AKRO) assumed with a Buy at H.C. Wainwright, tgt $72
    • Arcturus Therapeutics (ARCT) assumed with a Buy at H.C. Wainwright, tgt $60
    • AptarGroup (ATR) initiated with an Overweight at KeyBanc, tgt $220
    • Black Diamond Therapeutics (BDTX) initiated with a Buy at Guggenheim, tgt $8
    • C4 Therapeutics (CCCC) initiated with a Buy at Guggenheim, tgt $8
    • Critical Metals (CRML) initiated with a Buy at Clear Street, tgt $12
    • e.l.f. Beauty (ELF) assumed with an Overweight at Piper Sandler, tgt $150
    • Entergy (ETR) initiated with a Buy at Jefferies, tgt $109
    • Ideaya Biosciences (IDYA) initiated with an Outperform at Citizens JMP, tgt $41
    • Ideaya Biosciences (IDYA) initiated with an Overweight at Barclays, tgt $40
    • Janux Therapeutics (JANX) initiated with a Buy at Guggenheim, tgt $72
    • Kura Oncology (KURA) initiated with a Neutral at Guggenheim
    • Lifecore Biomedical (LFCR) initiated with a Sector Weight at KeyBanc
    • Madrigal Pharmaceuticals (MDGL) assumed with a Buy at H.C. Wainwright, tgt $500
    • MasTec (MTZ) initiated with an Outperform at Mizuho, tgt $215
    • MetaVia (MTVA) assumed with a Buy at H.C. Wainwright, tgt $12
    • Middleby (MIDD) initiated with an Outperform at Wolfe Research, tgt $163
    • Nuvalent (NUVL) assumed with a Buy at Guggenheim, tgt $122
    • Oric Pharmaceuticals (ORIC) assumed with a Buy at Guggenheim, tgt $18
    • Primoris (PRIM) initiated with a Neutral at Mizuho, tgt $112
    • Pyxis Oncology (PYXS) initiated with a Buy at Guggenheim, tgt $5
    • Quanta Services (PWR) initiated with a Neutral at Mizuho, tgt $360
    • Relay Therapeutics (RLAY) assumed with a Buy at Guggenheim, tgt $15
    • Sociedad Quimica y Minera (SQM) resumed with an Outperform at Itau BBA, tgt $55
    • Summit Therapeutics (SMMT) initiated with a Buy at Guggenheim, tgt $40
    • Syndax (SNDX) assumed with a Buy at Guggenheim, tgt $34
    • Terns Pharmaceuticals (TERN) assumed with a Neutral at H.C. Wainwright
    • TransMedics (TMDX) initiated with a Hold at Stifel, tgt $115
    • Ulta Beauty (ULTA) assumed with an Overweight at Piper Sandler, tgt $590